KRd consolidation for newly diagnosed multiple myeloma

KRd consolidation for newly diagnosed multiple myeloma - OCHA KRd observational research

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000046436

Enrollment

Registered

2022-01-27

Start date

2022-01-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple myeloma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Patient who is planed KRd consolidation. 2.Patient who provided written consents for this study.

Exclusion criteria

Exclusion criteria: 1.Patient who has passed for more than 180 days after ASCT. 2.Patient who has progressed after ASCT

Design outcomes

Primary

Measure	Time frame
The response rate after 4 cycles of KRd	—

Countries

Japan

Contacts

Public ContactDaisuke Kudo

Tokyo-kita Medical Center Department of hematology

daisukekud@jadecom.jp03-5963-3311

Outcome results